By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation and analyze site usage.

Discovery Data Pipeline

Acellera Therapeutics differential approach to drug discovery is reflected by a uniquely large pipeline of target data with high biological and disease validation.

We offer target-specific collaborations on these or any other targets you may be interested in.
Pipeline
Target
Target Class
Approach
Therapeutic Area
Druggability Assessment
Hit Identification
Hit-to-Lead
Lead Optimization
Orthosteric
Non-small cell lung cancer
Done
Done
Done
In progress
In progress
In progress
-
-
-
Orthosteric
Solid tumors
Done
Done
Done
In progress
In progress
In progress
-
-
-
Orthosteric
Colorectal Cancer
Done
Done
Done
In progress
In progress
In progress
-
-
-
Orthosteric
Immuno-oncology
Done
Done
Done
In progress
In progress
In progress
-
-
-
Allosteric
Longevity
Done
Done
Done
-
-
-
-
-
-
Allosteric
Inflammatory disease
Done
Done
Done
-
-
-
-
-
-
Allosteric
Renal cell carcinoma
Done
Done
Done
-
-
-
-
-
-
Allosteric
Multiple sclerosis
Done
Done
Done
-
-
-
-
-
-
Orthosteric
Infectious diseases
Done
Done
Done
-
-
-
-
-
-
Allosteric
Acute myeloid leukaemia
Done
In progress
In progress
-
-
-
-
-
-
Agonist
Sleeping disorders
Done
In progress
In progress
-
-
-
-
-
-
Agonist
Multiple sclerosis
Done
In progress
In progress
-
-
-
-
-
-
Allosteric
Metastatic breast cancer
Done
In progress
In progress
-
-
-
-
-
-
Allosteric
Pancreatic cancer
Done
In progress
In progress
-
-
-
-
-
-

Get in touch to know more details.